International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 37-42 , July 2010

A new-generation 5-nitroimidazole can induce highly metronidazole-resistant Giardia lamblia in vitro

  • Linda A. Dunn

      Affiliations

    • Molecular Genetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Qld 4006, Australia
    • ,
  • Anita G. Burgess

      Affiliations

    • Molecular Genetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Qld 4006, Australia
    • ,
  • Kenia G. Krauer

      Affiliations

    • Molecular Genetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Qld 4006, Australia
    • ,
  • Lars Eckmann

      Affiliations

    • Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA
    • ,
  • Patrice Vanelle

      Affiliations

    • Laboratoire de Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Universités d’Aix-Marseille I, II et III – CNRS, UMR 6264: Laboratoire Chimie Provence, 27 Bd Jean Moulin, 13385 Marseille Cedex 05, France
    • ,
  • Maxime D. Crozet

      Affiliations

    • Laboratoire de Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Universités d’Aix-Marseille I, II et III – CNRS, UMR 6264: Laboratoire Chimie Provence, 27 Bd Jean Moulin, 13385 Marseille Cedex 05, France
    • ,
  • Frances D. Gillin

      Affiliations

    • Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA
    • ,
  • Peter Upcroft

      Affiliations

    • Molecular Genetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Qld 4006, Australia
    • ,
  • Jacqueline A. Upcroft

      Affiliations

    • Molecular Genetics Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Brisbane, Qld 4006, Australia
    • Corresponding Author InformationCorresponding author. Present address: The Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Brisbane, Qld 4029, Australia. Tel.: +61 7 3362 0369; fax: +61 7 3362 0105.

Received 6 November 2009 ,Accepted 3 March 2010.

References 

  1. Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 2001;14:150–164
  2. Tan KSW. New insights on classification, identification, and clinical relevance of Blastocystis spp.. Clin Microbiol Rev. 2008;21:639–665
  3. Land KM, Johnson PJ. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist Updat. 1999;2:289–294
  4. Edwards DI. Nitroimidazole drugs—action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother. 1993;31:9–20
  5. Townson SM, Hanson GR, Upcroft JA, Upcroft P. A purified ferredoxin from Giardia duodenalis. Eur J Biochem. 1994;220:439–446
  6. Müller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery. 1983;93:165–171
  7. Leitsch D, Kolarich D, Wilson IBH, Altmann F, Duchêne M. Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase. PLoS Biol. 2007;5:1820–1834
  8. Leitsch D, Kolarich D, Binder M, Stadlmann J, Altmann F, Duchêne M. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Mol Microbiol. 2009;72:518–536
  9. Dunne RL, Dunn LA, Upcroft P, O’Donoghue PJ, Upcroft JA. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res. 2003;13:239–249
  10. Valdez CA, Tripp JC, Miyamoto Y, Kalisiak J, Hruz P, Andersen YS, et al. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia. J Med Chem. 2009;52:4038–4053
  11. Crozet MD, Botta C, Gasquet M, Curti C, Rémusat V, Hutter S, et al. Lowering of 5-nitroimidazole's mutagenicity: towards optimal antiparasitic pharmacophore. Eur J Med Chem. 2009;44:653–659
  12. Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, et al. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. J Antimicrob Chemother. 2000;46:819–821
  13. Townson SM, Upcroft JA, Upcroft P. Characterisation and purification of pyruvate:ferredoxin oxidoreductase from Giardia duodenalis. Mol Biochem Parasitol. 1996;79:183–193
  14. Liu SM, Brown DM, O’Donoghue P, Upcroft P, Upcroft JA. Ferredoxin involvement in metronidazole resistance of Giardia duodenalis. Mol Biochem Parasitol. 2000;108:137–140
  15. Müller J, Sterk M, Hemphill A, Müller N. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother. 2007;60:280–287
  16. Upcroft JA, Campbell RW, Benakli K, Upcroft P, Vanelle P. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.. Antimicrob Agents Chemother. 1999;43:73–76
  17. Upcroft JA, Dunn LD, Wright JM, Benakli K, Upcroft P, Vanelle P. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother. 2006;50:344–347
  18. Upcroft JA, Boreham PFL, Campbell RW, Shepherd RW, Upcroft P. Biological and genetic analysis of a longitudinal collection of Giardia samples derived from humans. Acta Trop. 1995;60:35–46
  19. Townson SM, Laqua H, Upcroft P, Boreham PFL, Upcroft JA. Induction of metronidazole and furazolidone resistance in Giardia. Trans R Soc Trop Med Hyg. 1992;86:521–522
  20. Boreham PFL, Phillips RE, Shepherd RW. Altered uptake of metronidazole in vitro by stocks of Giardia intestinalis with different drug sensitivities. Trans R Soc Trop Med Hyg. 1988;82:104–106
  21. Clark CG, Diamond LS. Methods for cultivation of luminal parasitic protists of clinical importance. Clin Microbiol Rev. 2002;15:329–341
  22. Upcroft JA, Upcroft P. Drug susceptibility testing of anaerobic protozoa. Antimicrob Agents Chemother. 2001;45:1810–1814
  23. Boreham PFL, Phillips RE, Shepherd RW. A comparison of the in-vitro activity of some 5-nitroimidazoles and other compounds against Giardia intestinalis. J Antimicrob Chemother. 1985;16:589–595
  24. Upcroft JA, Campbell RW, Upcroft P. Quinacrine-resistant Giardia duodenalis. Parasitology. 1996;112:309–313
  25. Upcroft J, Mitchell R, Chen N, Upcroft P. Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in β-tubulin. Microb Drug Resist. 1996;2:303–308
  26. Boreham PFL, Phillips RE, Shepherd RW. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother. 1984;14:449–461
  27. Dan M, Wang AL, Wang CC. Inhibition of pyruvate–ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme. Mol Microbiol. 2000;36:447–456
  28. Argüello-García R, Cruz-Soto M, Romero-Montoya L, Ortega-Pierres G. In vitro resistance to 5-nitroimidazoles and benzimidazoles in Giardia duodenalis: variability and variation in gene expression. Infect Genet Evol. 2009;9:1057–1064
  29. Wright JM, Dunn LA, Upcroft P, Upcroft JA. Efficacy of antigiardial drugs. Expert Opin Drug Saf. 2003;2:529–541
  30. Brown DM, Upcroft JA, Upcroft P. A H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis. Eur J Biochem. 1996;241:155–161
  31. Argüello-García R, Cruz-Soto M, Romero-Montoya L, Ortega-Pierres G. Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. J Antimicrob Chemother. 2004;54:711–721
  32. Rasoloson D, Vanácová S, Tomková E, Rázga J, Hrdy I, Tachezý J, et al. Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology. 2002;148:2467–2477
  33. Pal D, Banerjee S, Cui J, Schwartz A, Ghosh SK, Samuelson J. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases). Antimicrob Agents Chemother. 2009;53:458–464
  34. Upcroft P. Drug resistance in Giardia: clinical versus laboratory isolates. Drug Resist Updat. 1998;1:166–168

PII: S0924-8579(10)00119-6

doi: 10.1016/j.ijantimicag.2010.03.004

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 37-42 , July 2010

Article Tools

* Image Usage & Resolution